From: The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention
genotype(n/%)
Allele frequency(n/%)
HWE
GG
GA
AA
G
A
CYP2C19*2
78(48.75)
65(40.62)
17(10.63)
221(69.06)
99(30.94)
0.533
CYP2C19*3
140(87.5)
20(12.5)
0(0)
300(93.75)
20(6.25)
0.152
PONQ192R
73(45.62)
64(40)
23(14.38)
210(65.62)
110(34.38)
0.4